Clinical Trial Update: Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP

View source ↗

Summary

Special-use survey results assess the safety and efficacy of Cosentyx (secukinumab) in pediatric patients with psoriasis vulgaris, psoriatic arthritis, and gene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Pustular Psoriasis
• Psoriasis Vulgaris
• Psoriatic Arthritis

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Psoriasis Vulgaris, Psoriatic Arthritis | Status: COMPLETED